RxDoctor Payments Data

Leo Robb, DO

Family Medicine · Colleyville, TXNPI 1760461685

Payments from drug & device makers

$1,888in general payments, 2019–2025

Across 107 payments — averaging $17.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$338
  • Pfizer$183
  • Johnson & Johnson$181
  • Amgen$168
  • Astellas Pharma US Inc$151
  • Lilly USA, LLC$150
  • plus $717 from 16 others

What the payments were for

  • Food & beverage$1,888100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,888 in reported general payments places this provider in the 70th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$69,128
Medicare patients
233
Services billed
1,317

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide124$146,016
Trelegy ElliptaFluticasone/Umeclidin/Vilanter83$73,546
JardianceEmpagliflozin49$60,400
EliquisApixaban50$55,975
OzempicSemaglutide37$54,627
RybelsusSemaglutide16$29,500
XareltoRivaroxaban22$23,301
Repatha SureclickEvolocumab23$19,028
EntrestoSacubitril/Valsartan11$16,538
MyrbetriqMirabegron11$10,007
SymbicortBudesonide/Formoterol Fumarate19$6,791
SynthroidLevothyroxine Sodium68$5,781
Levothyroxine Sodium314$3,455
Albuterol Sulfate HfaAlbuterol Sulfate97$3,314
Atorvastatin Calcium503$3,183

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$150$146,016124 claims
Novo NordiskOzempic, Rybelsus$338$84,12753 claims
GSKTrelegy Ellipta$142$73,54683 claims
PfizerEliquis$183$55,97550 claims
Johnson & JohnsonXarelto$181$23,30122 claims
NovartisEntresto$65$16,53811 claims
Astellas Pharma US IncMyrbetriq$151$10,00711 claims
AstraZenecaSymbicort$79$6,79119 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Colleyville

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →